Innovative Eyewear, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, reporting third-quarter net revenue of $1,009,696 and a net loss of $2,287,141.

Key Highlights

  • Q3 2026 net revenue: $1,009,696, compared to $668,128 in Q3 2025, according to the filing.
  • Q3 2026 net loss: $2,287,141, or $0.27 loss per share basic and diluted, versus a $1,836,267 net loss in Q3 2025.
  • Nine-month net loss: $6,267,327 for the nine months ended September 30, 2026, compared to $5,721,064 for the same period in 2025.
  • Warrant inducement transaction: A July 2026 warrant inducement transaction resulted in the issuance of 2,200,544 shares, raising $2,562,272 in additional paid-in capital.
  • Cash and equivalents: $3,197,061 as of September 30, 2026, down from $6,511,036 as of December 31, 2025.
  • Shares outstanding: 8,712,263 shares issued and outstanding as of November 9, 2026, up from 5,479,861 as of December 31, 2025.
  • Accumulated deficit: $38,594,446 as of September 30, 2026, compared to $32,327,119 as of December 31, 2025.

Innovative Eyewear Reports Higher Q3 Revenue With Increased Operating Losses

According to the filing, Innovative Eyewear, Inc. (NASDAQ:LUCY) reported net revenues of $1,009,696 for the three months ended September 30, 2026, an increase from $668,128 in the comparable prior-year period. For the nine months ended September 30, 2026, net revenues totaled $2,793,776 versus $1,701,859 for the same period in 2025. The company's gross profit for Q3 2026 was $320,910, compared to $244,837 in Q3 2025.

The filing disclosed that total operating expenses for Q3 2026 were $2,659,283, up from $2,165,664 in Q3 2025. General and administrative expenses rose to $1,578,047 from $1,277,308 year over year, while research and development expenses increased to $423,353 from $129,984. Sales and marketing expenses declined to $622,883 from $723,372. The resulting Q3 2026 net loss was $2,287,141, compared to $1,836,267 in Q3 2025, with weighted average shares outstanding of 8,418,433 and 4,870,014, respectively.

The balance sheet as of September 30, 2026 showed total assets of $8,208,535 and total liabilities of $836,314, leaving total stockholders' equity of $7,372,221. The company completed a July 2026 warrant inducement transaction, issuing 2,200,544 shares and recording proceeds of $2,562,272. During Q1 2026, the company also raised $1,411,455 through at-the-market offerings. The filing notes that forward-looking statements are subject to risks and uncertainties described in Part II, Item 1A and in the company's other filings with the SEC.

What Was Disclosed

Innovative Eyewear filed its Q3 2026 Form 10-Q covering the period ended September 30, 2026, disclosing increased revenues alongside a wider net loss, a reduced cash balance, a higher share count following a warrant inducement transaction, and a growing accumulated deficit.